Viewing StudyNCT00430534



Ignite Creation Date: 2024-05-05 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00430534
Status: COMPLETED
Last Update Posted: 2007-02-02
First Post: 2007-02-01

Brief Title: Evaluation of Safety Immune-Response and Efficacy of GSK Biologicals EBV Epstein Barr Virus Vaccine 268664
Sponsor: Henogen
Organization: Henogen

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2007-02-01
First Submit QC Date: February 1 2007
Study First Post Date: 2007-02-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-02-01
Last Update Post Date: 2007-02-02
Last Update Post Date Type: ESTIMATED